Displaying items 37-48 of 206
» View courant.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-18
•
Next >
-
FDA approves two Glaxo melanoma drugs and companion diagnostic
ReutersMay 29 (Reuters) - U.S. health regulators on Wednesday approved a pair of GlaxoSmithKline Plc drugs to treat advanced melanoma - the deadliest form of skin cancer - in patients with specific genetic mutations, along with a diagnostic test to detect the...Tags: Skin Cancer, Food and Drug Administration, Medical Procedures and Tests
-
FDA approves skin cancer drugs and genetic test
The Food and Drug Administration on Wednesday announced its approval of two new drugs and a diagnostic test that can be used to treat advanced or inoperable melanoma, the most dangerous form of skin disease. Advanced melanoma has joined a wide range...
Tags: Squamous Cell Cancer, Health Treatments, Chemotherapy, Skin Cancer, General Practitioners
-
GSK boosts vaccines with 250 mln euros Okairos acquisition
ReutersLONDON, May 29 (Reuters) - GlaxoSmithKline boosted its vaccine business on Wednesday by agreeing to acquire Swiss-based vaccine technology company Okairos for 250 million euros ($321 million). Britain's biggest drugmaker said the private company had a...Tags: Disease Prevention, Chemical Industry, Preventative Medicine, Vaccines, Pharmaceuticals
-
Wall Street posts first weekly loss since mid-April on Fed angst
ReutersNEW YORK (Reuters) - The S&P 500 declined for a third day on Friday, with the three major stock indexes posting their first negative week since mid-April on lingering concern that the central bank may scale back its stimulus measures to support the...Tags: Level 3 Communications Incorporated, Fossil Incorporated, MBIA Incorporated, Philadelphia (Philadelphia, Pennsylvania), Tim Cook
-
RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug
ReutersBy Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...Tags: Disease Prevention, Yeast Infection, Trials, Boil (skin condition), Hospitals and Clinics
-
GSK flu shot may raise adult narcolepsy risk -Finnish scientists
ReutersHELSINKI/LONDON, May 23 (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday....Tags: Disease Prevention, Flu Vaccine, Finland, Preventative Medicine, Sleep Disorders
-
Glaxo to develop new antibiotics
The Philadelphia InquirerPHILADELPHIA A unit of drugmaker GlaxoSmithKline has a central role in a $200 million public-private project announced Wednesday to develop new antibiotics against biological terrorism and treat drug-resistant infections found in health care settings...Tags: Research and Development, Chemical Industry, Science and Technology, Pharmaceuticals, The Philadelphia Inquirer
-
Pointing to threat, pulling in profit
Tribune Washington BureauWASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...Tags: Lobbying, U.S. Centers for Disease Control and Prevention, Science, Defense, Biological and Chemical Weapons
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Chemotherapy, Health Treatments, Science and Technology, Bristol Myers Squibb Company, HIV
-
U.S. government taps GlaxoSmithKline for new antibiotics
ReutersLONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its kind between...Tags: Chemical Industry, Science, Science and Technology, Medical Specialization, Pharmaceuticals
-
Inmunoterapia contra el cáncer podrÃa ser un mercado de 35.000 mln dlrs anuales
ReutersPor Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podrÃa convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...Tags: Roche Holding AG, Amgen Inc., Novartis AG, AstraZeneca Plc, Bristol Myers Squibb Company
-
Gobierno de EEUU firma acuerdo con GlaxoSmithKline para nuevos antibióticos
ReutersLONDRES, 22 mayo (Reuters) - El Gobierno de Estados Unidos firmó un acuerdo para desarrollo de antibióticos valorado en más de 200 millones de dólares con GlaxoSmithKline para enfrentar la doble amenaza de la resistencia a los fármacos y el...
May 29, 2013
|Story| Reuters
May 29, 2013
|Story| Los Angeles Times
May 29, 2013
|Story| Reuters
May 24, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| McClatchy-Tribune
May 19, 2013
|Story| Los Angeles Times
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.
